Ribociclib (Kisqali)



I work in the Policy and Campaigns Team at Breast Cancer Care and I wanted to ask if anyone is currently taking, or has, the drug ribociclib in combination with fulvestrant? You could help shape our response to the SMC assessment that will decide whether it is available on the NHS Scotland.


The Scottish Medicines Consortium (SMC) is currently assessing the drug ribociclib in combination with fulvestrant for treating advanced hormone-receptor positive breast cancer.


We want to hear from people who have received this drug combination to help shape what we say to SMC about this drug.


If you can help, please get in touch with us and tell us your story


If you have any questions about our work in this area, please email campaigns@breastcancercare.org.uk


Thanks for your help,